As managed care expands in the United States, few prescribed therapeutics today are purchased completely out-of-pocket. Rather, most are covered, at least in part, by a third-party payer, such as a traditional managed care organization (MCO) or government entity.

Even so, the pharmaceutical industry continues to allocate minimal marketing resources and attention toward traditional managed care.

Read More